| Daniel Naish, PT | |
|
10000 N 31st Ave #a102, Phoenix, AZ 85051-9568 | |
| (602) 866-0066 | |
| (602) 866-3868 |
| Full Name | Daniel Naish |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 10000 N 31st Ave #a102, Phoenix, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013069269 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 964 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Naish, PT 10000 N 31st Ave #a102, Phoenix, AZ 85051-9568 Ph: (602) 866-0066 | Daniel Naish, PT 10000 N 31st Ave #a102, Phoenix, AZ 85051-9568 Ph: (602) 866-0066 |
News Archive
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.
The ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase. The extended collaboration, which is funded by the Muscular Dystrophy Association, aims to advance the development of Oxford BioMedica's preclinical gene therapy candidate, MoNuDin®, and to evaluate other gene-based strategies for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
An article published in the May 2010 issue of Postgraduate Medicine highlights the seriousness of cardiovascular disease (CVD) in patients with type 2 diabetes. Cardiovascular disease is the cause of death in > 65% of patients with diabetes, and when complicated by the presence of obesity, the lifetime risk of developing CVD increases to 90%. The inherent problem is that many of the antihyperglycemic medications used to combat high glycated hemoglobin are associated with weight gain and/or hypoglycemia, which negatively affect CVD.
Testing for malaria could become as simple as putting on a bandage.
› Verified 8 days ago
Mrs. Judith Savage Shoup, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10251 N 35th Ave, Phoenix, AZ 85051 Phone: 602-995-7366 Fax: 602-995-0867 | |
Ms. Hillary Kristi Vance, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 20045 N 19th Ave, Building 8, Phoenix, AZ 85027 Phone: 623-594-9034 Fax: 623-594-9868 | |
Dr. Sarah Buschmann, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5055 E Washington St, Phoenix, AZ 85034 Phone: 602-277-1073 | |
Dr. Haley Dudzinski, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2942 N 7th Ave Ste A101, Phoenix, AZ 85013 Phone: 602-277-0084 Fax: 602-277-0885 | |
Kendra Ann Scott, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 202 E Earll Dr Ste 360, Phoenix, AZ 85012 Phone: 480-788-5621 Fax: 480-779-1277 | |
Dr. Taylor Wingstrom, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 41818 N Venture Dr Ste 120, Phoenix, AZ 85086 Phone: 623-742-7338 | |
Steven Notaro, Physical Therapist Medicare: Medicare Enrolled Practice Location: 2222 E Highland Ave Ste 310, Phoenix, AZ 85016 Phone: 602-512-8550 |